Advertisement

Topics

Alphamer Technology gets Seed Fundraising to Fight Antibiotic Resistance

09:01 EST 20 Feb 2017 | Labiotech.eu

Centauri Therapeutics has raised £1.2M in the second part of its seed round, which will be directed at bringing its first alphamer to the preclinical stage. Centauri Therapeutics, a young British biotech, is developing alphamer technology to fights infectious disease and ...

This awesome article Alphamer Technology gets Seed Fundraising to Fight Antibiotic Resistance appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Alphamer Technology gets Seed Fundraising to Fight Antibiotic Resistance

NEXT ARTICLE

More From BioPortfolio on "Alphamer Technology gets Seed Fundraising to Fight Antibiotic Resistance"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...